Gaining a better comprehension of non-neuronal contributions, differences in commonly used mouse models, and the mode of action of HDAC inhibitors will help in advancing our understanding of SMA pathogenesis and the development of novel therapeutic strategies. Here, HDAC9 is linked to proximal spinal muscular atrophy.